Back to Search
ELIZABETH BREUER, MD
MD
Obstetrics & Gynecology Physician
NPI: 1467772749IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
042.0012846(VT)65327-20(WI)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
CLVLND CLINIC LERNER COLLEGE OF MED OF CASE WSTN RSV UNIVERSITY
Class of 2010
Research & Publications (20)
[Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation].
PMID 18810445·Pathologe·2008
8-other
Assessment of metal concentrations found within a North Sea drill cuttings pile.
PMID 18499193·Mar Pollut Bull·2008
8-other
Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.
PMID 18257543·J Med Chem·2008
7-preclinical
The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
PMID 17653090·Oncogene·2008
8-other
Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata.
PMID 17550431·Med Vet Entomol·2007
7-preclinical
The multiple Maillard reactions of ribose and deoxyribose sugars and sugar phosphates.
PMID 17850774·Carbohydr Res·2007
8-other
Supercontinuum generation system for optical coherence tomography based on tapered photonic crystal fibre.
PMID 19503487·Opt Express·2006
8-other
Methyltrifluoropyruvate imines possessing N-oxalyl and N-phosphonoformyl groups--precursors to a variety of alpha-CF3-alpha-amino acid derivatives.
PMID 16990943·Org Biomol Chem·2006
8-other
Carbamoylphosphonate matrix metalloproteinase inhibitors 3: in vivo evaluation of cyclopentylcarbamoylphosphonic acid in experimental metastasis and angiogenesis.
PMID 15897594·Clin Cancer Res·2005
7-preclinical
Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.
PMID 15139760·J Med Chem·2004
7-preclinical
Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding group.
PMID 14762707·J Biol Inorg Chem·2004
8-other
Drill cutting accumulations in the Northern and Central North Sea: a review of environmental interactions and chemical fate.
PMID 14725872·Mar Pollut Bull·2004
6-review
Core protein dependence of epimerization of glucuronosyl residues in galactosaminoglycans.
PMID 12207034·J Biol Chem·2002
8-other
Incidence and tumour stages of breast cancer in the region of Aachen, Germany.
PMID 11966831·Eur J Cancer Care (Engl)·2002
8-other
Primary breast cancer therapy in six regions of Germany.
PMID 11872353·Eur J Cancer·2002
4-observational
High reactivity of alkyl sulfides towards epoxides under conditions of collagen fixation--a convenient approach to 2-amino-4-butyrolactones.
PMID 11516082·Biomaterials·2001
7-preclinical
[Solitary fibrous thoracic wall tumor. Progression with percutaneous radiotherapy].
PMID 11200659·Dtsch Med Wochenschr·2001
5-case
Different usage of the glycosaminoglycan attachment sites of biglycan.
PMID 11145959·J Biol Chem·2001
7-preclinical
The effect of topical delivery of novel bisacylphosphonates in reducing alveolar bone loss in the rat model.
PMID 11063394·J Periodontol·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 201 N MAYFAIR RD
WAUWATOSA, WI 53226 - Phone
- (414) 771-8828
Quick Facts
- NPI
- 1467772749
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile